Predictive Value of Electromechanical Activation Time for In-Hospital Major Cardiac Adverse Events in Heart Failure Patients
Objective. This prospective study aimed to evaluate the value of the cardiac cycle time-corrected electromechanical activation time (EMATc) measured at admission for predicting major cardiac adverse events (MACEs) in hospitalized patients with chronic heart failure (CHF). Methods. CHF patients with...
Main Authors: | Jing Zhang, Wen-Xian Liu, Shu-Zheng Lyu |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi-Wiley
2020-01-01
|
Series: | Cardiovascular Therapeutics |
Online Access: | http://dx.doi.org/10.1155/2020/4532596 |
Similar Items
-
Effectiveness of Modified HEART Score in Predicting Major Adverse Cardiac Events
by: Sultan Tuna Akgol Gur, et al.
Published: (2021-02-01) -
Lower Plasma Elabela Levels in Hypertensive Patients With Heart Failure Predict the Occurrence of Major Adverse Cardiac Events: A Preliminary Study
by: Zheng Ma, et al.
Published: (2021-03-01) -
Left Ventricular Function and Myocardial Triglyceride Content on 3T Cardiac MR Predict Major Cardiovascular Adverse Events and Readmission in Patients Hospitalized with Acute Heart Failure
by: Kuang-Fu Chang, et al.
Published: (2020-01-01) -
Plasma IL-37 Elevated in Patients with Chronic Heart Failure and Predicted Major Adverse Cardiac Events: A 1-Year Follow-Up Study
by: Xiling Shou, et al.
Published: (2017-01-01) -
Heart Rate Variability Predicts Major Adverse Cardiovascular Events and Hospitalization in Maintenance Hemodialysis Patients
by: Jiun-Chi Huang, et al.
Published: (2017-03-01)